Omsal (Tamsulosin Hydrochloride)

Tamsulosin selectively blocks alpha‑1A adrenergic receptors in the prostate, bladder neck and urethra. This receptor blockade relaxes smooth‑muscle tone in these areas, decreasing resistance to urine flow and easing lower urinary tract symptoms.

The prescribed dose of Omsal is determined by a qualified healthcare professional based on the patient’s condition, age, kidney and liver function, and other medications. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Tamsulosin is not indicated for use in women, and safety data in pregnancy or lactation are lacking. It should only be used by men with BPH; women who are pregnant or breastfeeding should avoid the medication unless specifically directed by a physician.

To order Omsal, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Omsal (tamsulosin) is an alpha‑1 blocker that provides rapid symptom relief by relaxing prostate smooth muscle. Other classes, such as 5‑alpha‑reductase inhibitors (e.g., finasteride), work by shrinking prostate size over months. Choice of therapy depends on symptom severity, prostate size and patient tolerance.

Omsal tablets should be stored at temperatures below 25 °C, in the original packaging, and protected from moisture and direct sunlight. Keep the product out of reach of children and do not use after the expiry date.

Omsal is taken orally, usually once daily, with or without food. The tablet should be swallowed whole with a glass of water and not crushed or chewed, unless the prescribing physician advises otherwise.

Serious risks include severe orthostatic hypotension, allergic reactions such as anaphylaxis, and rare events like priapism. Patients should seek immediate medical attention if they experience fainting, rash, swelling, or a prolonged erection.

Men with known hypersensitivity to tamsulosin or any component of the tablet, those taking strong CYP3A4 inhibitors, or patients with severe liver impairment should avoid Omsal unless a physician determines that benefits outweigh risks.